TYR and type 2 diabetes mellitus: In contrast, the non-polar extracts exhibited higher anti-enzymatic activity compared to the polar extracts against key enzymes targeted in the management of chronic diseases such as Alzheimer’s (acetylcholinesterase, butyrylcholinesterase), type 2 diabetes mellitus (amylase, glucosidase), and skin disorders (tyrosinase).